TNDM Estados financieros: Análisis de Tandem Diabetes Care Inc AI

Inicio

Acciones

TNDM

TNDM Financiero

Tandem Diabetes Care Inc

$18.95

1.39%

$0.25

Al cierre: Feb 13, 16:00:00 GMT-5

$18.95

Mercado Posterior: Feb 13, 20:00:00 GMT-5

Visión general Pronóstico Ganando Dividendos Finanzas

Ingreso

Balance general

Flujo de efectivo

Anual

Trimestral

TNDM Ingreso

Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Ingresos	1,007	940	747	801	702	498
Crecimiento de los Ingresos (YoY)	18%	26%	-7%	14%	41%	38%
Costo de los ingresos	470	450	380	388	326	238
Utilidad bruta	536	489	367	413	376	260
Venta, General y Administración	426	389	352	335	261	204
Investigación y Desarrollo	196	198	169	170	92	63
Gastos de Operación	623	588	522	505	353	268
Otras Ingresos (Gastos) No Operativos	--	--	--	--	--	--
Ingreso antes de impuestos	-204	-91	-220	-92	15	-36
Gasto por Impuesto a la Renta	-1	4	2	1	0	-1
Ingreso Neto	-203	-96	-222	-94	15	-34
Crecimiento de la Utilidad Neta	61%	-56.99%	136%	-727%	-144%	42%
Acciones en Circulación (Diluidas)	67.65	65.45	64.96	64.1	64.3	61
Cambio de Acciones (YoY)	3%	1%	1%	0%	5%	4%
EPS (Diluido)	-3	-1.46	-3.42	-1.47	0.24	-0.56
Crecimiento de EPS	55%	-56.99%	133%	-713%	-143%	33%
Flujo de efectivo libre	-71	-41	-83	7	87	-7
Flujo de efectivo libre por acción	--	--	--	--	--	--
Margen bruto	53.22%	52.02%	49.12%	51.56%	53.56%	52.2%
Margen de operación	-8.54%	-10.53%	-20.61%	-11.48%	3.13%	-1.6%
Margen de beneficio	-20.15%	-10.21%	-29.71%	-11.73%	2.13%	-6.82%
Margen de flujo de caja libre	-7.05%	-4.36%	-11.11%	0.87%	12.39%	-1.4%
EBITDA	-69	-83	-139	-78	35	2
Margen de EBITDA	-6.85%	-8.82%	-18.6%	-9.73%	4.98%	0.4%
D&A para EBITDA	17	16	15	14	13	10
EBIT	-86	-99	-154	-92	22	-8
Margen de EBIT	-8.54%	-10.53%	-20.61%	-11.48%	3.13%	-1.6%
Tasa de Impuesto Efectiva	0.49%	-4.39%	-0.9%	-1.08%	0%	2.77%

Estadísticas clave

Cierre Anterior

$18.69

Precio de apertura

$18.95

Rango del día

$18.49 - $19.49

Rango de 52 semanas

$9.98 - $37.71

Volumen

753.1K

Volumen promedio

1.8M

EPS (TTM)

-3.49

Rendimiento de dividendos

Cap. de mercado

$1.2B

¿Qué es TNDM?

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.



Características

Copiloto de IA para Acciones y Criptomonedas

Predicción de precios

Seguimiento de Recaudación de Fondos

Temas

Comparación de Criptomonedas

Recursos